The virtual EASD Annual Meeting 2021 has ended
and we would like to thank all participants who joined us during the congress!
Registered delegates have exclusive on-demand access to presentation recordings until 31 October 2021. Please click the ACCESS HERE banner above or login to your MyEASD account to watch the recordings. Certificates/CME will be available for download via your MyEASD account, for more information please see here.
EASD TV - Discussion on Covid-19 and diabetes at EASD 2021
EASD TV discussion with Chantal Mathieu, Mikael Rydén and Amar Puttanna about the impact of Covid-19 on diabetes.
Also available on YouTube:
"Are women with diabetes at higher cardiovascular risk?" - Interview with Alexandra Kautzky-Willer and Naveed Sattar. more
EMPEROR-Preserved Trial - Discussing key results with Stefan D. Anker. more
Are you a junior doctor interested in research? Have you just started your research fellowship? Do you need training in clinical research design and analysis?
The interactive and highly successful EASD Robert Turner Course returns to the face-to-face format in 2022 and is hosted again by Oxford University’s Clinical Departments. It is open to clinically qualified doctors with an interest in research in endocrinology and diabetes.
EFSD welcomes applications for the following programmes:
EFSD and Lilly EXPLORING AND APPLYING NEW STRATEGIES IN DIABETES (EXPAND) Programme
Application Deadline: 2 November 2021
EFSD and EUDF Digitalisation in Diabetes Care Research Grant
Application Deadline: 15 November 2021
EFSD New Targets for Diabetes or Obesity-related Metabolic Diseases
Application Deadline: 1 December 2021
The European Foundation for the Study of Diabetes (EFSD) was created by EASD to provide funding in all areas of diabetes research across the entire European Region. The aims of EFSD are to encourage and support groundbreaking diabetes research and to promote the next generation of leading diabetes researchers. more
Impact Factor 2020: 10.1
Diabetologia is the Journal of the EASD and publishes original clinical, translational and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. more